Clinical Trial Update: Replacement of Nebulised Ipratropium With Inhaled Tiotropium in Stable Chronic Obstructive Pulmonary Disease (COPD) [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating replacing nebulised ipratropium with inhaled tiotropium in stable chronic obstructive pulmonary disease has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• IPRATROPIUM BROMIDE (IPRATROPIUM BROMIDE)
• tiotropium bromide (tiotropium)

Snippet

Sponsor: NHS Greater Glasgow and Clyde | Conditions: Chronic Obstructive Pulmonary Disease | Phase 4 | Status: WITHDRAWN